Mark Corrigan - 28 Jul 2021 Form 4 Insider Report for Nabriva Therapeutics plc

Role
Director
Signature
/s/ Robert Crotty, by power of attorney
Issuer symbol
N/A
Transactions as of
28 Jul 2021
Net transactions value
$0
Form type
4
Filing time
30 Jul 2021, 20:18:55 UTC
Previous filing
04 Jun 2021
Next filing
18 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Award $0 +17,500 $0.000000 17,500 28 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBRV Share Options Award $0 -35,000 -50% $0.000000 35,000 28 Jul 2021 Ordinary Shares 35,000 $1.08 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units.
F2 The option was granted on July 28, 2021.
F3 One hundred percent (100%) of the option will vest on July 31, 2022, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.